ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 41 filers reported holding AC IMMUNE SA in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2021$320,000
-15.3%
47,7150.0%0.00%
Q2 2021$378,000
-61.2%
47,715
-62.8%
0.00%
-100.0%
Q1 2021$975,000
+48.9%
128,098
+1.1%
0.00%0.0%
Q4 2020$655,000
-33.5%
126,707
-37.2%
0.00%
-50.0%
Q3 2020$985,000
-27.3%
201,919
+0.3%
0.00%0.0%
Q2 2020$1,355,000
-2.6%
201,3190.0%0.00%
-50.0%
Q1 2020$1,391,000
+961.8%
201,319
+1207.3%
0.00%
Q4 2019$131,000
-24.3%
15,400
-28.8%
0.00%
Q3 2018$173,00021,6440.00%
Other shareholders
AC IMMUNE SA shareholders Q4 2018
NameSharesValueWeighting ↓
BVF INC/IL 11,297,911$55,925,0005.88%
Prosight Management, LP 1,248,453$6,180,0003.43%
PA Capital LLC 76,257$377,0000.37%
Artal Group S.A. 1,000,000$4,950,0000.20%
Temasek Holdings (Private) Ltd 2,614,095$12,940,0000.10%
COHEN LAWRENCE B 13,350$66,0000.04%
Tekla Capital Management LLC 171,813$850,0000.04%
Athanor Capital, LP 108,540$537,0000.04%
GSA CAPITAL PARTNERS LLP 28,600$142,0000.02%
APPLETON PARTNERS INC/MA 11,525$57,0000.01%
View complete list of AC IMMUNE SA shareholders